gantenerumab (RG1450) - Roche, Novartis
|
traneurocin oral (NA-831) - Biomed Industries
|
crenezumab (RG7412) - AC Immune
|
Aduhelm (aducanumab) - Neurimmune, Eisai
|
semorinemab (RG6100) - AC Immune
|
Leqembi (lecanemab-irmb) - Biogen, Eisai
|
solanezumab (LY2062430) - Eli Lilly
|
bapineuzumab (AAB-001) - Pfizer, J&J, Perrigo Company
|
Kisunla (donanemab-azbt) - Eli Lilly
|